# Abbott Laboratories (ABT) total liabilities history

URL: https://funkfolio.com/stock/ABT/total-liabilities

> Abbott Laboratories (ABT) total liabilities were $33.94B at the end of fiscal 2025, up 1.3% from fiscal 2024. Year-by-year chart and table.

---

## Abbott Laboratories (ABT) total liabilities

**Total liabilities · fiscal 2025:** $33.94B at Dec 31, 2025

Abbott Laboratories (ABT) had total liabilities of $33.94B at the end of fiscal 2025 (December 31, 2025). That is 1.3% higher than the $33.51B of fiscal 2024. Figures as of 18 Nov 2026, 20:27 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Total liabilities, fiscal 2025:** $33.94B
- **Change on fiscal 2024:** +1.3%
- **Highest on record:** $37.53B fiscal 2022
- **Lowest on record:** $33.51B fiscal 2024
- **Fiscal years on record:** 4 2022–2025

Figures as of 18 Nov 2026, 20:27 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

### Abbott Laboratories total liabilities, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $37.53B in fiscal 2022 and the lowest $33.51B in fiscal 2024.

### Total liabilities by fiscal year

### Abbott Laboratories total liabilities, year by year

Abbott Laboratories (ABT) total liabilities by fiscal year

| Fiscal year | Total liabilities | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | $33.94B | 1.3% up | Dec 31, 2025 |
| 2024 | $33.51B | 2.5% down | Dec 31, 2024 |
| 2023 | $34.39B | 8.4% down | Dec 31, 2023 |
| 2022 | $37.53B | — | Dec 31, 2022 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

### How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

### Total liabilities at health care companies of similar size

Total liabilities of Abbott Laboratories and comparable companies

| Company | Total liabilities | Fiscal year |
| --- | --- | --- |
| Abbott Laboratories ABT | $33.94B | 2025 |
| [Novo Nordisk NVO](https://funkfolio.com/stock/NVO/total-liabilities) | DKK 348.86B | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### Abbott Laboratories, figure by figure

- [Abbott Laboratories market cap](https://funkfolio.com/stock/ABT/market-cap)
- [Abbott Laboratories revenue](https://funkfolio.com/stock/ABT/revenue)
- [Abbott Laboratories earnings](https://funkfolio.com/stock/ABT/earnings)
- [Abbott Laboratories earnings per share (EPS)](https://funkfolio.com/stock/ABT/eps)
- [Abbott Laboratories P/E ratio](https://funkfolio.com/stock/ABT/pe-ratio)
- [Abbott Laboratories P/S ratio](https://funkfolio.com/stock/ABT/ps-ratio)
- [Abbott Laboratories P/B ratio](https://funkfolio.com/stock/ABT/pb-ratio)
- [Abbott Laboratories free cash flow](https://funkfolio.com/stock/ABT/free-cash-flow)
- [Abbott Laboratories operating margin](https://funkfolio.com/stock/ABT/operating-margin)
- [Abbott Laboratories dividend](https://funkfolio.com/stock/ABT/dividend)
- [Abbott Laboratories shares outstanding](https://funkfolio.com/stock/ABT/shares-outstanding)
- [Abbott Laboratories total debt](https://funkfolio.com/stock/ABT/total-debt)
- [Abbott Laboratories cash on hand](https://funkfolio.com/stock/ABT/cash)
- [Abbott Laboratories total assets](https://funkfolio.com/stock/ABT/total-assets)
- [Abbott Laboratories net assets (shareholders' equity)](https://funkfolio.com/stock/ABT/net-assets)
- [Abbott Laboratories return on equity (ROE)](https://funkfolio.com/stock/ABT/roe)
- [Abbott Laboratories return on invested capital (ROIC)](https://funkfolio.com/stock/ABT/roic)

[Abbott Laboratories (ABT) overview: price, valuation and scorecard](https://funkfolio.com/stock/ABT) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Abbott Laboratories total liabilities: questions and answers

**How large are Abbott Laboratories's total liabilities?**

Abbott Laboratories (ABT) had total liabilities of $33.94B at the end of fiscal 2025 (December 31, 2025). That is 1.3% higher than the $33.51B of fiscal 2024.

**What are the highest and lowest total liabilities figures on record for Abbott Laboratories?**

Across the 4 fiscal years on record (2022–2025), the highest was $37.53B in fiscal 2022 and the lowest $33.51B in fiscal 2024.

**How is Abbott Laboratories's total liabilities calculated?**

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Abbott Laboratories it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

### Learn: total liabilities

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Market cap vs enterprise value: what is the difference?](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

  Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Abbott Laboratories (ABT) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/ABT/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.
